News

December 9, 2022

WashU’s nasal COVID-19 vaccine approved for use as booster in India

Many more people now eligible for vaccine delivered via nose drops.

News Release

October 4, 2022

WashU COVID-19 nasal vaccine technology licensed to Ocugen

Aim is for commercialization in U.S., Europe, Japan.

Medical Campus & Community